DOCSLIB.ORG

Non-Invasive Respiratory Support Is a Pro-Inflammatory Stimulus to the Upper and Lower Airways

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Non-Invasive Respiratory Support Is a Pro-Inflammatory Stimulus to the Upper and Lower Airways NON-INVASIVE RESPIRATORY SUPPORT IS A PRO-INFLAMMATORY STIMULUS TO THE UPPER AND LOWER AIRWAYS Mohammed D. AlAhmari MSc RRT A thesis submitted for the degree of Doctor of Philosophy UCL, UK 2012 Centre for Respiratory Medicine Royal Free Campus University College London 1 DECLARATION “I, Mohammed Dhafer AlAhmari, confirm that the work presented in this thesis is my own except for the help listed in the acknowledgements. Where information has been derived from other sources, I confirm that this has been indicated in the thesis” Signuture: ………………… Date: ……………………… 2 ACKNOWLEDGEMENTS It is with my sincerest gratitude that I take this opportunity to thank those without whom this PhD thesis would not have been possible. Firstly, I especially want to express my deepest thanks to Professor Wisia Wedzicha who accepted me into her Centre of Respiratory Medicine and supported me throughout my PhD study. I would also like to thank my supervisor Dr. John Hurst, for his valuable guidance and insightful advice, encouragement, patience, and his suggestions and constant support during my PhD journey. Thank you for being so easy to approach at any time! I am certain that the completion of my thesis would not have been possible without his guidance. Special thanks goes to Ray Sapsford, our lab manager, for helping, teaching and assisting me with sample processing and analysing, and the setup of the in-vitro study. I would also like to express my thanks to Christine Mikelsons, Consultant Respiratory Physiotherapy, who helped and assisted me in the recruitment of OSA patients. Without her support, I believe the study of OSA would not have been possible to do. Thank you! I would also like to thank Gavin Donaldson who assisted with the power calculations of the thesis, and the suggestions he gave whenever I approached him. I would like to that the following colleagues for their help and support: Dr. James Goldring, Dr. Anant Patel, Dr. Alex Mackay, Beverly Kowlessar, and all other department colleagues for their friendship and help they readily gave during the process. This work would not have been possible without the generosity of the healthy volunteers and the patience they displayed while being on the CPAP machine for three hours. My thanks also go to OSA and COPD patients and their families. I would like to thank the Saudi Ministry of Higher Education for supporting my studies and the sponsorship of my PhD. 3 Last, but not least, I thank my wife and my three beautiful children for their understanding and support throughout my entire educational process. 4 ABSTRACT Non-invasive respiratory support (NIV) is associated with a high prevalence of local side- effects which may be associated with induction of upper airway inflammation. This thesis examines the effect of NIV on the upper and lower airway by examining bronchial epithelial cell cultures, healthy subjects, obstructive sleep apnoea (OSA), and chronic obstructive pulmonary disease (COPD) patients. The rationale for this thesis is based on reports suggesting that continuous positive airway pressure (CPAP) may induce early upper airway inflammation, and discusses the relationship between upper and lower airways in COPD. To examine the addressed rationale we used both an in vitro and in vivo approach. In vitro, we examined the release of the inflammatory cytokines from a human bronchial epithelial cell line over time-intervals using CPAP therapy. In vivo studies investigated whether induction of nasal inflammation was associated with the development of systemic inflammation, nasal symptoms, and changes in nasal mucociliary clearance after a short period of CPAP therapy. Results were investigated further in OSA by investigating whether induction of nasal inflammation was associated with the development of systemic inflammation, nasal symptoms, airway obstruction, and impaired adherence to CPAP therapy and quality of sleepiness over a six months follow-up period. Additional pilot data obtained involved a comparison of local and systemic inflammatory indices in COPD patients using and not using NIV. The key finding was that CPAP is pro-inflammatory. The in vitro data showed that CPAP resulted in the release of inflammatory mediators from cultured human bronchial epithelial cells, in a time-and-pressure-dependent manner. Meanwhile, in vivo data from healthy control subjects showed CPAP was associated with dose (pressure) response changes in nasal and systemic inflammatory markers, reduced nasal function, and the development of nasal symptoms. The development of nasal symptoms was associated with the degree of functional impairment and nasal inflammatory response. These in vitro and in vivo results were novel in reporting the effects of CPAP in this way, providing new data on the mechanisms of CPAP intolerance in the crucial, early phase of therapy. Furthermore, the long-term CPAP study with OSA resulted in nasal inflammation, reduction in nasal 5 mucociliary function, and significant other adverse effects. However, sleep quality and the perceived benefits of therapy improved over time, despite the presence of side-effects. These results have important implications for clinical practice, since it demonstrates a relationship between nasal symptoms, mucociliary clearance, inflammation and compliance in patients with OSA initiating and continuing CPAP therapy. Further investigation of strategies to combat the initial side-effects and nasal inflammation associated with this treatment modality might target the epithelial lining of the nose in an attempt to address the origin of the inflammatory response. In addition, educational and support strategies to improve patients‟ tolerance of side effects may further increase compliance with nasal CPAP treatment for OSA patients. 6 ABBREVIATIONS °C Degree Celsius AASM American Academy of Sleep Medicine AAT Alpha1-antitrypsin AECOPD Acute exacerbation of chronic obstructive pulmonary disease AHI Apnoea-Hypopnoea Index AHR Airway hyperresponsiveness ALI Acute lung injury ANOVA Analysis of Variance AR Acoustic rhinometry ARDS Acute Respiratory Distress Syndrome BEAS-2B Bronchial epithelial cell line BMI Body-mass index BODE Body mass index, obstruction, dyspnea, exercise capacity index cm Centimeter CO Carbon monoxide CO2 Carbon dioxide COPD Chronic Obstructive Pulmonary Disease CPAP Continuous positive airway pressure CRP C-reactive protein CSA Cross sectional area CT Computed Tomography CV Coefficient of variation CXCR Chemokine receptor D-MCA Distance of cross-sectional area from nasal orifice EBC Exhaled breath condensate ECM Extracellular matrix ECP Eosinophil cationic protein 7 EDS Excessive daytime sleepiness EEG Electroencephalography ELISA Enzyme-linked immunosorbent assay EPAP Expiratory positive airway pressure EPO Erythropoietin ESS Epworth Sleepiness Scale ETDA Ethylenediaminetetraacetic acid FeNO Fractional exhaled nitric oxide FEV1 Forced expiratory volume in 1 second FRC Functional residual capacity FVC Forced vital capacity GOLD Global Initiative for Chronic Obstructive Lung Disease GPRD General Practice Research Database GSH Glutathione H2O Water (hydrogen dioxide) ICAM-1 Inter-Cellular Adhesion Molecule-1 ICC Intraclass correlation coefficients IF Inflammatory factors IFN-γ Interferon-gamma IL Interleukin IPAP Inspiratory positive airway pressure IPPV Intermittent positive pressure ventilation Kg Kilogram L Liter MCA1 First minimum cross-sectional area MCA2 Second minimum cross-sectional area MMP Matrix metalloproteinases MPO Myeloperoxidase MRI Magnetic Resonance Imaging MSLT The multiple sleep latency test 8 N Number NaCl Sodium chloride nCPAP Nasal continuous positive airway pressure NHS National Health Service NIV Non-invasive ventilation MCC mucociliary clearance NO Nitric oxide O2 Oxygen OSA Obstructive sleep apnoea P Pressure PaCO2 Partial arterial pressure of carbon dioxide Paw Airway pressure PBS Phosphate buffered saline PEEP Positive end-expiratory pressure PEFR Peak expiratory flow rate PND Post-nasal drip R Pearson correlation co-efficient RDI Respiratory disturbance index Rho Spearman rank correlation co-efficient RMM Rhinomanometry rpm revolutions per minute S Second SaO2 Blood oxygen saturation SGRQ St. George‟s Respiratory Questionnaire STT Saccharin transit time SD Standard deviation STT Saccharin transit time T Temperature TIMP Tissue inhibitors of matrix metalloproteinases TCC Total cell count 9 TGF-β Transforming growth factor-beta TNF-α Tumour necrosis factor-alpha UARS Upper airway resistance syndrome UK United Kingdom μm Micrometer USA United States of America V Volume v/v volume for volume nd th V2-5 Volume of nasal cavity between the 2 and 5 cm from nasal orifice VEGF Vascular endothelial growth factor VIP Vasoactive intestinal peptide VT Tidal volume w/v Weight/volume WHO World Health Organization WOB Work of breathing VEGF Vascular endothelial growth factor 10 TABLE OF CONTENTS 2 DECLARATION ACKNOWLEDGEMENTS 3 ABSTRACT 5 ABBREVIATIONS 7 TABLE OF CONTENTS 11 LIST OF TABLES 21 LIST OF FIGURES 23 LIST OF PLATES 26 Chapter 1 INTRODUCTION 27 1.1 OVERVIEW OF THE RESPIRATORY SYSTEM 27 1.1.1 Structure of Upper Airway 29 1.1.1.1 Part of the Upper Respiratory Tract 29 1.1.2 Structure of Lower Airway 30 1.1.2.1 Part of the Lower Respiratory Tract 31 11 1.2 CONTINUOUS POSITIVE AIRWAY PRESSURE 33 (CPAP) 1.2.1 Definition and History 33 1.2.2 Indications and Contraindications of CPAP Therapy 35 1.2.2.1 Indications of CPAP Therapy 35 1.2.2.2 Contraindications of CPAP Therapy 35 1.2.2.3 CPAP-Related Side Effects 36 1.3 BiLEVEL
Load more

Recommended publications
  • Nasal Airflow Measured by Rhinomanometry Correlates with Feno in Children with Asthma
    RESEARCH ARTICLE Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma I-Chen Chen1☯, Yu-Tsai Lin2☯, Jong-Hau Hsu1,3, Yi-Ching Liu1, Jiunn-Ren Wu1,3, Zen- Kong Dai1,3* 1 Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2 Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, 3 Department of Pediatrics, School of Medicine, College of Medicine, a11111 Kaohsiung Medical University, Kaohsiung, Taiwan ☯ These authors contributed equally to this work. * [email protected] Abstract OPEN ACCESS Citation: Chen I-C, Lin Y-T, Hsu J-H, Liu Y-C, Wu Background J-R, Dai Z-K (2016) Nasal Airflow Measured by Rhinitis and asthma share similar immunopathological features. Rhinomanometry is an Rhinomanometry Correlates with FeNO in Children with Asthma. PLoS ONE 11(10): e0165440. important test used to assess nasal function and spirometry is an important tool used in doi:10.1371/journal.pone.0165440 asthmatic children. The degree to which the readouts of these tests are correlated has yet Editor: Stelios Loukides, National and Kapodistrian to be established. We sought to clarify the relationship between rhinomanometry measure- University of Athens, GREECE ments, fractional exhaled nitric oxide (FeNO), and spirometric measurements in asthmatic Received: September 3, 2016 children. Accepted: October 11, 2016 Methods Published: October 28, 2016 Patients' inclusion criteria: age between 5 and 18 years, history of asthma with nasal symp- Copyright: © 2016 Chen et al. This is an open toms, and no anatomical deformities. All participants underwent rhinomanometric evalua- access article distributed under the terms of the Creative Commons Attribution License, which tions and pulmonary function and FeNO tests.
    [Show full text]
  • Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy
    Medical Coverage Policy Effective Date ............................................. 7/10/2021 Next Review Date ....................................... 3/15/2022 Coverage Policy Number .................................. 0554 Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy Table of Contents Related Coverage Resources Overview .............................................................. 1 Balloon Sinus Ostial Dilation for Chronic Sinusitis and Coverage Policy ................................................... 2 Eustachian Tube Dilation General Background ............................................ 3 Drug-Eluting Devices for Use Following Endoscopic Medicare Coverage Determinations .................. 10 Sinus Surgery Coding/Billing Information .................................. 10 Rhinoplasty, Vestibular Stenosis Repair and Septoplasty References ........................................................ 28 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence
    [Show full text]
  • Medical Policy Directory of Documents Policy Number: 411
    Medical Policy Directory of Documents Policy Number: 411 Q: How do I comment on the documents? A: You can email us at [email protected]. Q: How do I find out which documents have changed? A: New and updated documents are posted to the system every week. To find out what has changed see the Provider Focus newsletter. Drugs ∙ Treatments ∙ Devices and Equipment ∙ Surgeries ∙ Other Drugs Medical Technology Assessment Investigational (Non-Covered) Services List 400 Ampyra™ (dalfampridine) 246 Antihyperlipidemics: A Prescription Drug Therapy Guideline 013 ↳Prior Authorization/ Formulary Exception Form 434 Anti-Parkinsonism Drugs 054 Antisense Oligonucleotide Medications 027 Asthma and Chronic Obstructive Pulmonary Disease Medication Management 011 ↳Prior Authorization/ Formulary Exception Form 434 Benign Prostatic Hyperplasia (BPH) 040 Bisphosphonate, Oral 058 Botulinum Toxin Injections 006 B-Type Natriuretic Peptide 031 Anti-Migraine Policy 021 CNS Stimulants and Psychotherapeutic Agents 019 Compound Exclusion List for Pharmacy Medical Policy 579, Compounded Medications 705 Compound Inclusion List for Pharmacy Medical Policy 579, Compounded Medications 704 Compounded Medications 579 Cox II Inhibitor Drugs 002 Diabetes Step Therapy 041 Dificid (fidaxomicin) 700 Drug Management and Prior Authorization 251 ↳Prior Authorization/ Formulary Exception Form 434 Drugs for Cystic Fibrosis 408 Entresto Step Therapy 063 Erythropoietin, Recombinant Human; Epoetin Alpha (Epogen and Procrit); Darbepoetin Alpha 262 (Aranesp) Esketamine Nasal Spray (Spravato)
    [Show full text]
  • Does the Reduction of Inferior Turbinate Affect Lower Airway Functions?
    Braz J Otorhinolaryngol. 2019;85(1):43---49 Brazilian Journal of OTORHINOLARYNGOLOGY www.bjorl.org ORIGINAL ARTICLE Does the reduction of inferior turbinate affect lower ଝ airway functions? a,∗ a b a Ozlem Unsal , Mehtap Ozkahraman , Mufide Arzu Ozkarafakili , Meltem Akpinar , a a a Arzu Yasemin Korkut , Senem Kurt Dizdar , Berna Uslu Coskun a Sisli Hamidiye Etfal Training and Research Hospital, Clinic of Otorhinolaryngology, Istanbul, Turkey b Sisli Hamidiye Etfal Training and Research Hospital, Clinic of Pulmonary Diseases, Istanbul, Turkey Received 31 July 2017; accepted 16 October 2017 Available online 6 November 2017 KEYWORDS Abstract Acoustic rhinometry; Introduction: Although the nose and lungs are separate organs, numerous studies have reported Turbinates; that the entire respiratory system can be considered as a single anatomical and functional unit. Hypertrophy; The upper and lower airways affect each other either directly or through reflex mechanisms. Spirometry; Objective: In this study, we aimed to evaluate the effects of the radiofrequency ablation of Respiratory system persistent inferior turbinate hypertrophy on nasal and pulmonary function. Methods: Twenty-seven patients with bilateral persistent inferior turbinate hypertrophy with- out septal deviation were included in this study. All of the patients were evaluated using anterior rhinoscopy, nasal endoscopy, acoustic rhinometry, a visual analogue scale, and flow-sensitive spirometry on the day before and 4 months after the radiofrequency ablation procedure. Results: The post-ablation measurements revealed that the inferior turbinate ablation caused an increase in the mean cross-sectional area and volume of the nose, as well as in the forced expiratory volume in 1 s, forced vital capacity, and peak expiratory flow of the patients.
    [Show full text]
  • Heated and Humidified High-Flow Oxygen Therapy Reduces Discomfort During Hypoxemic Respiratory Failure
    Heated and Humidified High-Flow Oxygen Therapy Reduces Discomfort During Hypoxemic Respiratory Failure Elise Cuquemelle MD, Tai Pham MD, Jean-Franc¸ois Papon MD PhD, Bruno Louis PhD, Pierre-Eric Danin MD, and Laurent Brochard MD PhD BACKGROUND: Non-intubated critically ill patients are often treated by high-flow oxygen for acute respiratory failure. There is no current recommendation for humidification of oxygen devices. METHODS: We conducted a prospective randomized trial with a final crossover period to compare nasal airway caliber and respiratory comfort in patients with acute hypoxemic respiratory failure receiving either standard oxygen therapy with no humidification or heated and humidified high- flow oxygen therapy (HHFO2) in a medical ICU. Nasal airway caliber was measured using acoustic rhinometry at baseline, after 4 and 24 hours (H4 and H24), and 4 hours after crossover (H28). Dryness of the nose, mouth, and throat was auto-evaluated and assessed blindly by an otorhinolaryngologist. After the crossover, the subjects were asked which system they preferred. RESULTS: Thirty subjects completed the protocol and were analyzed. Baseline median oxygen flow was 9 and 12 L/min in the ؍ standard and HHFO2 groups, respectively (P .21). Acoustic rhinometry measurements showed no difference between the 2 systems. The dryness score was significantly lower in the HHFO2 group at H4 During the crossover period, dryness increased promptly .(004. ؍ and H24 (0 vs 8, P (007. ؍ vs 6, P 2) ؍ after switching to standard oxygen and decreased after switching to HHFO2 (P .008). Sixteen subjects ؍ (53%) preferred HHFO2 (P .01), especially those who required the highest flow of oxygen at admis- ؍ sion (P .05).
    [Show full text]
  • And Post-Pyriform Plasty Nasal Airflow
    Braz J Otorhinolaryngol. 2018;84(3):351---359 Brazilian Journal of OTORHINOLARYNGOLOGY www.bjorl.org ORIGINAL ARTICLE Evaluation of pre- and post-pyriform plasty nasal airflowଝ ∗ Oscimar Benedito Sofia , Ney P. Castro Neto, Fernando S. Katsutani, Edson I. Mitre, José E. Dolci Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, SP, Brazil Received 29 November 2016; accepted 28 March 2017 Available online 6 May 2017 KEYWORDS Abstract Introduction: Nasal obstruction; Nasal obstruction is a frequent complaint in otorhinolaryngology outpatient clin- Rhinomanometry; ics, and nasal valve incompetence is the cause in most cases. Scientific publications describing Acoustic rhinometry surgical techniques on the upper and lower lateral cartilages to improve the nasal valve are also quite frequent. Relatively few authors currently describe surgical procedures in the piri- form aperture for nasal valve augmentation. We describe the surgical technique called pyriform plasty and evaluate its effectiveness subjectively through the NOSE questionnaire and objec- tively through the rhinomanometry evaluation. Objective: To compare pre- and post-pyriform plasty nasal airflow variations using rhinomanom- etry and the NOSE questionnaire. Methods: Eight patients submitted to pyriform surgery were studied. These patients were screened in the otorhinolaryngology outpatient clinic among those who complained of nasal obstruction, and who had a positive response to Cottle maneuver. They answered the NOSE questionnaire and were submitted to preoperative rhinomanometry. After 90 days, they were reassessed through the NOSE questionnaire and the postoperative rhinomanometry. The results of these two parameters were compared pre- and postoperatively. Results: Regarding the subjective measure, the NOSE questionnaire, seven patients reported improvement, of which two reported marked improvement, and one patient reported an unchanged obstructive condition.
    [Show full text]
  • The Potential of Computational Fluid Dynamics Simulations of Airflow in the Nasal Cavity
    Berger et al., J Neurobiol Physiol 2021; Journal of Neurobiology and Physiology 3(1):10-15. Short Communication The potential of computational fluid dynamics simulations of airflow in the nasal cavity Berger M1,2, Pillei M1,3, Freysinger W2* 1Department of Environmental, Process Abstract & Energy Engineering, MCI – The Entrepreneurial School, Austria Computational Fluid Dynamics (CFD) is a well-established and accepted tool for simulation and prediction of complex physical phenomena e.g., in combustion, aerodynamics or blood circulation. 2University Hospital of Recently CFD has entered the medical field due to the readily available high computational power of Otorhinolaryngology, Medical current graphics processing units, GPUs. Efficient numerical codes, commercial or open source, are University Innsbruck, Austria available now. Thus, a wide range of medical themes is available for CFD almost in real-time in the 3Department of Fluid Mechanics, medical environment now. Friedrich-Alexander University The available methods are on the point of reaching a usability status ready for everyday clinical use Erlangen-Nuremberg, Germany as a potential medical decision support system, provided adherence to the appropriate patient data *Author for correspondence: protection rules and proper certification as a medical device. Email: wolfgang.freysinger@i-med. ac.at This contribution outlines the current range of activities in our clinic in the field of Lattice-Boltzmann CFD based on CT and / or MR imagery and flashlights the following three areas: simulating the effect Received date: November 05, 2020 of nasal stents on breathing, predicting clinical Rhinomanometry and Rhinometry, and the numerical Accepted date: February 23, 2021 estimation of resection volumes for surgery to improve nasal breathing.
    [Show full text]
  • Subjective and Objective Improvement in Breathing After Rhinoplasty
    ORIGINAL ARTICLE ONLINE FIRST Subjective and Objective Improvement in Breathing After Rhinoplasty Richard A. Zoumalan, MD; Minas Constantinides, MD Objective: To determine whether rhinoplasty im- cedures undergone, including spreader grafts and alar bat- proves subjective and objective nasal patency. ten grafts, and on the absence of osteotomies. These groups had similar results. In patients with severe obstruction, Design: Retrospective study including subjective breath- all measured values improved more than any other sub- ing scores and acoustic rhinometry before and 6 to 9 group, including the MCA, which improved signifi- months after septorhinoplasty among a cohort of 31 pa- cantly by an average of 55%. Patients with normal pre- tients. We used a paired t test to analyze the difference operative MCA values did not experience any significant between preoperative and postoperative values. changes except for an anterior shift in MCA. Setting: Academic medical center. Conclusions: Septorhinoplasty increases nasal vol- ume, decreases nasal resistance, and advances the MCA Patients: Patients undergoing septorhinoplasty with po- anteriorly. These changes coexist with subjective im- tassium titanyl phosphate laser turbinate reduction at a single institution. provements in nasal patency, which suggests that this new anatomic configuration creates a positive outcome on na- Results: The mean subjective breathing scores im- sal airflow. Spreader grafts do not increase the MCA sig- proved significantly, with an overall improvement of 38%. nificantly. Patients with preoperative severe obstruc- The overall mean volume increased and the overall re- tion have the best overall improvement, whether measured sistance decreased, but the changes were significant only subjectively or objectively. on the right side.
    [Show full text]
  • Alteraes Na Mucosa Nasal Provocadas Pela Presso Atmosfrica, Oxignio E
    ALTERAÇÕES NA MUCOSA NASAL PROVOCADAS PELA PRESSÃO ATMOSFÉRICA, OXIGÉNIO E OUTROS FACTORES PAULO SÉRGIO ALVES VERA-CRUZ PINTO Dissertação de doutoramento em Ciências Médicas 2009 PAULO SÉRGIO ALVES VERA-CRUZ PINTO ALTERAÇÕES NA MUCOSA NASAL PROVOCADAS PELA PRESSÃO ATMOSFÉRICA, OXIGÉNIO E OUTROS FACTORES Dissertação de candidatura ao grau de Doutor em Ciências Médicas, submetida ao Instituto de Ciências Biomédicas de Abel Salazar da Universidade do Porto. Orientador – Professor Doutor Carlos Zagalo, professor do Instituto de Ciências da Saúde Egas Moniz. Co-Orientador – Professor Doutor Artur Águas, professor catedrático do Instituto de Ciências Biomédicas de Abel Salazar da Universidade do Porto. Porto 2009 2 À Carla, ao Gonçalo e ao Bernardo 3 4 “Try and leave this world a little better than you found it and when your turn come to die, you can die happy in feeling that at any rate you have not wasted your time but have done your best.” Lord Robert Baden-Powell's Last Message to Scouts, 1941 5 6 ÍNDICE Preceitos legais ...................................................................................................................9 Agradecimentos.................................................................................................................10 INTRODUÇÃO...................................................................................................................12 1- Anatomia das Fossas Nasais no Humano ................................................................12 2 - Anatomia das Fossas Nasais no Rato .....................................................................14
    [Show full text]
  • Partitioning of Inhaled Ventilation Between the Nasal and Oral Routes During Sleep in Normal Subjects
    J Appl Physiol 94: 883–890, 2003. First published November 1, 2002; 10.1152/japplphysiol.00658.2002. Partitioning of inhaled ventilation between the nasal and oral routes during sleep in normal subjects MICHAEL F. FITZPATRICK, HELEN S. DRIVER, NEELA CHATHA, NHA VODUC, AND ALISON M. GIRARD Department of Medicine, Queen’s University, Kingston, Ontario, Canada K7L 3N6 Submitted 18 July 2002; accepted in final form 28 October 2002 Fitzpatrick, Michael F., Helen S. Driver, Neela the snore vibration, which can originate from the soft Chatha, Nha Voduc, and Alison M. Girard. Partitioning palate or from the tongue base (30), may vary during of inhaled ventilation between the nasal and oral routes the night (10). In patients with obstructive sleep apnea during sleep in normal subjects. J Appl Physiol 94: 883–890, (OSA), one study demonstrated a change in the pri- 2003. First published November 1, 2002; 10.1152/jappl- mary site of upper airway obstruction with sleep stage, physiol.00658.2002.—The oral and nasal contributions to from the velopharyngeal level in non-REM sleep to the inhaled ventilation were simultaneously quantified during sleep in 10 healthy subjects (5 men, 5 women) aged 43 Ϯ 5 yr, hypopharyngeal level during REM sleep (4). Ϫ1 Ϫ1 The advent of the nasal cannula pressure transducer with normal nasal resistance (mean 2.0 Ϯ 0.3 cmH2O⅐l ⅐s ) by use of a divided oral and nasal mask. Minute ventilation as the preferred device for airflow measurement during awake (5.9 Ϯ 0.3 l/min) was higher than that during sleep sleep, because of its higher sensitivity for detection of (5.2 Ϯ 0.3 l/min; P Ͻ 0.0001), but there was no significant airflow limitation (27), is also predicated on the as- difference in minute ventilation between different sleep sumption that airflow during sleep is primarily via the stages (P ϭ 0.44): stage 2 5.3 Ϯ 0.3, slow-wave 5.2 Ϯ 0.2, and nasal route, regardless of sleep stage.
    [Show full text]
  • Proceedings of the British Thoracic Society
    Thorax 1983;38:700-719 Thorax: first published as 10.1136/thx.38.9.700 on 1 September 1983. Downloaded from Proceedings of the British Thoracic Society The 1983 Summer Meeting of the British Thoracic Society was held on 27-29 June in the University of Cambridge BTS smoking withdrawal study: fators assodated with four there was continuing "active" disease at the time of giving up smoking death. The average follow-up in this supplementary series is six years and to date there has been only one simple IA CAMPBELL for BTS Research Committee In the British tumour (neurilemmoma). Thoracic Society's smoking withdrawal study 9-7% of 1550 patients successfully gave up smoking. Reasons for wanting to stop smoking, apart from improvement in Treatment of pneumothorax by simple aspiration health, were expense (30%), dislike of addiction (20%) and "dirty habit" (18%). Concern about weight gain was AAD HAMILTON, GJ ARCHER All the patients admitted to expressed by 41% of men and 59% of women. Men were Stepping Hill Hospital with an uncomplicated more successful than women and success in both sexes pneumothorax requiring treatment during the 12 months increased with age. Men with ischaemic heart disease did up to January 1983 were admitted to the study. These best (21% success). Married or single men were more patients, numbering 10, were treated by simple aspiration likely to give up smoking than divorced or separated men. of air using a plastic cannula used for intravenous insertion. Patients whose "most important other person" was a non- In seven patients the procedure was successful.
    [Show full text]
  • Upper and Lower Respiratory Disease, Edited by J
    UPPER AND LOWER R ESP1RAT0 RY DISEASE Edited by Jonathan Corren Allergy Research Foundation, Inc. Los Angeles, California, U.S.A. Alkis Togias Johns Hopkins Asthma and Allergy Center Baltimore, Maryland, U.S.A. Jean Bousquet Hdpital Arnaud de Villeneuve Montpellier, France MARCEL MARCELDEKKER, INC. NEWYORK RASEL DEKKER Although great care has been taken to provide accurate and current information, neither the author(s) nor the publisher, nor anyone else associated with this publica- tion, shall be liable for any loss, damage, or liability directly or indirectly caused or alleged to be caused by this book. The material contained herein is not intended to provide specific advice or recommendations for any specific situation. Trademark notice: Product or corporate names may be trademarks or registered trade- marks and are used only for identification and explanation without intent to infringe. Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress. ISBN: 0-8247-0723-0 This book is printed on acid-free paper. Headquarters Marcel Dekker, Inc., 270 Madison Avenue, New York, NY 10016, U.S.A. tel: 212-696-9000; fax: 212-685-4540 Distribution and Customer Service Marcel Dekker, Inc., Cimarron Road, Monticello, New York 12701, U.S.A. tel: 800-228-1160; fax: 845-796-1772 Eastern Hemisphere Distribution Marcel Dekker AG, Hutgasse 4, Postfach 812, CH-4001 Basel, Switzerland tel: 41-61-260-6300; fax: 41-61-260-6333 World Wide Web http://www.dekker.com The publisher offers discounts on this book when ordered in bulk quantities.
    [Show full text]